General patient characteristics
Characteristic | HPV-Positive (n = 22) (50%) | HPV-Negative (n = 22) (50%) | P Value |
---|---|---|---|
Sex | .30 | ||
Male | 18 (81.8%) | 15 (68.2%) | |
Female | 4 (18.2%) | 7 (31.8%) | |
Age at diagnosis (yr) | .92 | ||
Median (range) | 57 (47–78) | 60.5 (45–71) | |
Oropharyngeal subsite | .29 | ||
Tonsil | 12 (54.4%) | 10 (45.5%) | |
Base of tongue | 8 (36.4%) | 6 (27.3%) | |
Oropharynx nos | 2 (9.1%) | 6 (27.3%) | |
Smokinga | .01 | ||
Never (0–5 pack years) | 8 (36.4%) | 0 (0%) | |
Moderate (6–24 pack years) | 5 (22.7%) | 5 (22.7%) | |
Heavy (>24 pack years) | 9 (40.9%) | 17 (77.3%) | |
Alcohol consumptionb | .02 | ||
Never (0) | 3 (13.6%) | 0 (0%) | |
Moderate (1–149 U years) | 15 (68.2%) | 10 (45.5%) | |
Heavy (>149 U years) | 4 (18.2%) | 12 (54.5%) | |
T-stage | .03 | ||
T2 | 12 (54.5%) | 5 (22.7%) | |
T3–4 | 10 (45.5%) | 17 (77.3%) | |
N-stage | .04 | ||
N0 | 0 (0%) | 5 (22.7%) | |
N1–3 | 22 (100%) | 17 (77.3%) | |
M-stage | NA | ||
M0 | 22 (100%) | 22 (100%) | |
M1 | 0 (0%) | 0 (0%) |